You are here

patents

Testing requirements are likely slowing biosimilar entries in the US

RAPS.org

Wed, 10/14/20 - 05:53 pm

Covid-19 Vaccine Frontrunner Moderna Won’t Enforce Vaccine Patents During Pandemic

Forbes

Thu, 10/8/20 - 10:52 am

Moderna Therapeutics

Teva back on the hook for $235M to GSK for heart drug infringement

Fierce Pharma

Mon, 10/5/20 - 11:42 pm

Patent Infringement

Medtronic Takes the Gloves Off in Patent War with Axonics

Medical Devices and Diagnostics Industry

Sat, 09/26/20 - 10:23 pm

sacral neuromodulation

Amarin loses patent appeal and their brief grip on a cardiovascular, fish oil empire

Endpoints

Fri, 09/4/20 - 12:04 am

Amarin Patent Appeal Is a Coin Toss With Billions on the Line

Yahoo/Bloomberg

Wed, 09/2/20 - 11:07 am

AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman

Fierce Pharma

Tue, 09/1/20 - 12:28 pm

Moderna failed to disclose federal funding for vaccine patent applications, advocates say

Stat

Sun, 08/30/20 - 12:02 am

Moderna Therapeutics

Department of Defense

U.S. court upholds patent for Novartis MS drug Gilenya

Reuters

Tue, 08/18/20 - 11:04 am

multiple sclerosis

Bristol Myers, Pfizer fend off a key challenge to their top-selling heart drug

BioPharma Dive

Thu, 08/6/20 - 10:27 am

Bristol-Myers Squibb

Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections

CP Wire

Mon, 08/3/20 - 10:17 am

Chelation Partners

antibiotic resistance

Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections

Mon, 08/3/20 - 09:59 am

Chelation Partners

antibiotic resistance

Moderna's Vaccine Technology Continues to be Tangled in Patent Challenges

BioSpace

Sat, 07/25/20 - 02:23 pm

Moderna Therapeutics

Arbutus BioPharma

Moderna's stock falls the day after 'disappointing' patent ruling

Marketwatch

Fri, 07/24/20 - 09:35 am

Moderna Therapeutics

Arbutus BioPharma

AbbVie, already famous for its Humira strategy, forms another 'patent wall' around Imbruvica: report

Fierce Pharma

Wed, 07/22/20 - 11:47 pm

AbbVie's 'drip-feed' of patents shields top cancer drug from competition, group says

BioPharma Dive

Wed, 07/15/20 - 11:12 pm

Amgen's Enbrel Patents to Be Upheld Through 2029

Motley Fool

Thu, 07/2/20 - 12:15 am

rheumatoid arthritis

Mylan, seeking to market Victoza generic, convinces panel to start up patent review

Fierce Pharma

Wed, 06/24/20 - 11:18 pm

Mylan, looking to capitalize on Biogen's Tecfidera patent loss, faces fork in the road on generic launch

Fierce Pharma

Mon, 06/22/20 - 08:36 pm

multiple sclerosis

Judge wipes out Biogen's Tecfidera patent protections in suit against Mylan

Fierce Pharma

Thu, 06/18/20 - 10:44 am

multiple sclerosis

Pages